Mirghaderi P, Pahlevan-Fallahy M, Rahimzadeh P, Habibi M, Pourjoula F, Azarboo A
J Orthop Surg Res. 2024; 19(1):848.
PMID: 39702480
PMC: 11657554.
DOI: 10.1186/s13018-024-05356-w.
Kavian A, Rezaee H, Darvari S, Mehrad-Majd H, Mashhadinejad H
Arch Bone Jt Surg. 2024; 12(6):412-417.
PMID: 38919740
PMC: 11195039.
DOI: 10.22038/ABJS.2024.74693.3458.
PLoS One. 2024; 19(4):e0298152.
PMID: 38626226
PMC: 11020928.
DOI: 10.1371/journal.pone.0298152.
Haac B, OHara N, Haut E, Manson T, Slobogean G, OToole R
OTA Int. 2024; 7(2):e331.
PMID: 38623266
PMC: 11013691.
DOI: 10.1097/OI9.0000000000000331.
Za P, Papalia G, Franceschetti E, Rizzello G, Adravanti P, Papalia R
Knee Surg Sports Traumatol Arthrosc. 2023; 31(10):4407-4421.
PMID: 37449989
DOI: 10.1007/s00167-023-07500-1.
Comparison of low-dose (162 mg) and high-dose (650 mg) Aspirin prophylaxis following total joint arthroplasty: a prospective cohort study.
Shafiei S, Rastegar M, Mirghaderi P, Siavashi B, Mortazavi S
Ann Med Surg (Lond). 2023; 85(5):1461-1467.
PMID: 37229014
PMC: 10205192.
DOI: 10.1097/MS9.0000000000000366.
Incidence of Symptomatic Venous Thromboembolism (VTE) in 8,885 Elective Total Hip Arthroplasty Patients Receiving Post-operative Aspirin VTE Prophylaxis.
Coveney E, Hutton C, Patel N, Whitehouse S, Howell J, Wilson M
Cureus. 2023; 15(3):e36464.
PMID: 37090282
PMC: 10117228.
DOI: 10.7759/cureus.36464.
Inpatient compliance with venous thromboembolism prophylaxis after orthopaedic trauma: results from a randomized controlled trial of aspirin versus low molecular weight heparin.
Haac B, OHara N, Manson T, Slobogean G, Castillo R, OToole R
OTA Int. 2021; 4(4):e150.
PMID: 34765900
PMC: 8575420.
DOI: 10.1097/OI9.0000000000000150.
Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial.
Haac B, OHara N, Manson T, Slobogean G, Castillo R, OToole R
PLoS One. 2020; 15(8):e0235628.
PMID: 32745092
PMC: 7398524.
DOI: 10.1371/journal.pone.0235628.
Thrombosis rates using aspirin and a compression device as multimodal prophylaxis for lower limb arthroplasty in a screened population.
An V, Levy Y, Walker P, Bruce W
J Clin Orthop Trauma. 2020; 11(Suppl 2):S187-S191.
PMID: 32189937
PMC: 7067987.
DOI: 10.1016/j.jcot.2018.10.007.
Implementation and Validation of the 2013 Caprini Score for Risk Stratification of Arthroplasty Patients in the Prevention of Venous Thrombosis.
Krauss E, Segal A, Cronin M, Dengler N, Lesser M, Ahn S
Clin Appl Thromb Hemost. 2019; 25:1076029619838066.
PMID: 30939898
PMC: 6714918.
DOI: 10.1177/1076029619838066.
Use of oral anticoagulants for the prevention of thromboembolic events in the post-operative period of hip arthroplasty: a systematic review.
Trevisol A, Coppi E, Pancotte J, Bortoluzzi E, Knop G
Rev Bras Ortop. 2018; 53(5):515-520.
PMID: 30245988
PMC: 6148076.
DOI: 10.1016/j.rboe.2018.07.005.
Centers for Disease Control and Prevention 2017 Guidelines for Prevention of Surgical Site Infections: Review and Relevant Recommendations.
Boyle K, Rachala S, Nodzo S
Curr Rev Musculoskelet Med. 2018; 11(3):357-369.
PMID: 29909445
PMC: 6105476.
DOI: 10.1007/s12178-018-9498-8.
Venous thromboembolism prophylaxis after total knee arthroplasty (TKA): aspirin rivaroxaban.
Colleoni J, Ribeiro F, Mos P, Reis J, Oliveira H, Miura B
Rev Bras Ortop. 2018; 53(1):22-27.
PMID: 29367902
PMC: 5771791.
DOI: 10.1016/j.rboe.2017.11.007.
Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions.
Azboy I, Barrack R, Thomas A, Haddad F, Parvizi J
Bone Joint J. 2017; 99-B(11):1420-1430.
PMID: 29092979
PMC: 5742873.
DOI: 10.1302/0301-620X.99B11.BJJ-2017-0337.R2.
The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.
Chu J, Maselli J, Auerbach A, Fang M
Thromb Res. 2017; 155:65-71.
PMID: 28501678
PMC: 5531185.
DOI: 10.1016/j.thromres.2017.04.012.
Letter to the Editor: Not the Last Word: Safety Alert: One in 200 Knee Replacement Patients Die Within 90 Days of Surgery.
Berstock J, Whitehouse M
Clin Orthop Relat Res. 2017; 475(4):1275-1276.
PMID: 28120294
PMC: 5339156.
DOI: 10.1007/s11999-017-5247-3.
Mortality after total hip replacement surgery: A systematic review.
Berstock J, Beswick A, Lenguerrand E, Whitehouse M, Blom A
Bone Joint Res. 2014; 3(6):175-82.
PMID: 24894596
PMC: 4054013.
DOI: 10.1302/2046-3758.36.2000239.
Venous Thromboembolism (VTE) Prophylaxis for Hip and Knee Arthroplasty: Changing Trends.
Budhiparama N, Abdel M, Ifran N, Parratte S
Curr Rev Musculoskelet Med. 2014; 7(2):108-16.
PMID: 24706152
PMC: 4092192.
DOI: 10.1007/s12178-014-9207-1.
The necessity of pharmacological prophylaxis against venous thromboembolism in major joint arthroplasty.
Yassin M, Mitchell C, Diab M, Senior C
Int Orthop. 2013; 38(5):1073-5.
PMID: 24352825
PMC: 3997761.
DOI: 10.1007/s00264-013-2233-6.